Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Malignant Lymphoma

  Free Subscription


Articles published in Dtsch Med Wochenschr

Retrieve available abstracts of 9 articles:
HTML format



Single Articles


    June 2021
  1. HENTRICH M
    [Diagnosis and treatment of HIV-associated lymphoma: Update 202].
    Dtsch Med Wochenschr. 2021;146:724-727.
    PubMed     Abstract available


  2. HENTRICH M
    [Diagnosis and treatment of HIV-associated lymphoma: Update 2021].
    Dtsch Med Wochenschr. 2021;146:e57.
    PubMed    


    February 2020
  3. FRIEDRICHS B, Schmitz N, Lenz G
    [Current diagnostic and therapeutic standards in aggressive B-cell lymphomas].
    Dtsch Med Wochenschr. 2020;145:151-154.
    PubMed     Abstract available


    January 2020
  4. WIENEMANN H, Brockelmann PJ, Adam M
    [Complete remission of Loeffler's endocarditis with Imatinib in a myeloid and lymphoid neoplasm associated with eosinophilia].
    Dtsch Med Wochenschr. 2020;145:36-39.
    PubMed     Abstract available


    November 2019
  5. HOHMANN C, Richardt T, Meinhardt A, Kaag N, et al
    [66-year-old Patient with acute Respiratory Distress Syndrome after Chemotherapy].
    Dtsch Med Wochenschr. 2019;144:1545-1546.
    PubMed    


    October 2019
  6. HOPFINGER G, Staber P
    [Current standard in diagnostic and therapy of peripheral T-cell lymphoma].
    Dtsch Med Wochenschr. 2019;144:1400-1404.
    PubMed     Abstract available


    February 2019
  7. SCHORB E, Illerhaus G, Finke J
    [Current Treatment Standards in PCNSL].
    Dtsch Med Wochenschr. 2019;144:161-164.
    PubMed     Abstract available


    April 2018
  8. FUCHS M
    [Hodgkin Lymphoma - Update 2018].
    Dtsch Med Wochenschr. 2018;143:466-470.
    PubMed     Abstract available


    January 2018
  9. BUSKE C, Dreyling M
    [Malignant B-Cell Lymphoma: Advances in the Therapy of Follicular Lymphoma and Mantle-cell Lymphoma].
    Dtsch Med Wochenschr. 2018;143:46-51.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: